The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel transposon BAFF CAR-T cells (LMY-920) for non-Hodgkin lymphoma (NHL).
 
Paolo Caimi
Stock and Other Ownership Interests - Abcon Therapeutics; ContaX biologics
Consulting or Advisory Role - Abbvie; Autolus Therapeutics; Bristol-Myers Squibb/Celgene; Genentech; Genmab; Novartis; Recordati; SOBI; Synthekine
Research Funding - Abbvie; ADC Therapeutics; Genmab (Inst); Luminary Therapeutics; Recordati (Inst)
Patents, Royalties, Other Intellectual Property - XaTEC patent holder (I)
Travel, Accommodations, Expenses - Pint Pharma
(OPTIONAL) Uncompensated Relationships - Abcon Therapeutics; Luminary Therapeutics
 
Matthew Spear
Employment - Dark Horse; Denovo Biopharma; Immunogenik; Luminary Therapeutics
Leadership - Dark Horse; Denovo Biopharma; Luminary Therapeutics
Stock and Other Ownership Interests - Dark Horse; Denovo Biopharma; Luminary Therapeutics
Consulting or Advisory Role - Dark Horse; Immunogenik; Luminary Therapeutics
 
Jeff Liter
Employment - Luminary Therapeutics
Leadership - Luminary Therapeutics
Stock and Other Ownership Interests - Luminary Therapeutics
 
Branden Moriarity
Employment - Department of Pediatrics, University of Minnesota,; Luminary Therapeutics
Leadership - Luminary Therapeutics
Stock and Other Ownership Interests - Luminary Therapeutics
 
Beau Webber
Employment - Department of Pediatrics, University of Minnesota,; Luminary Therapeutics
Leadership - Luminary Therapeutics
Stock and Other Ownership Interests - Luminary Therapeutics